During a vaccine clinical trial of Cytomegalovirus (CMV) vaccine, one of the participants' motivations was to prevent an infection responsible for malformations in a future child. Would their attitude towards a vaccine trial be the same in the context of a vaccine designed to protect them individually? By improving the knowledge of clinical research and determinants in women aged 18 to 40, this study could improve recruitment methods in this specific population for future vaccine trials within the CIC1408 infectious diseases and vaccinology area at Saint-Etienne University Hospital.
Womens between 18 to 40 included in CMVCTORY vaccine trial
Refusal
All french participants of the CMVCTORY vaccine trial.
Cohort
Retrospective
Qualitative interview
Other interventionInterview between participant and a researcher, in order to identity the determinants of participation in a clinical trial among participants in the CMVictory vaccine trial.
Quantitative questionnaire
Other interventionAnonymous online survey using a 3-part questionnaire, studying knowledge of clinical research and the determinants of participation in a preventive vaccine study in a population of young women (aged 18-40).
qualitative interview
To identify the motivations and the obstacles of participation in an experimental trial in women of childbearing age in Phase 3 trial.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
